Neutrophils and neutrophil extracellular traps orchestrate initiation and resolution of inflammation

Clinical and Experimental Rheumatology

Volumn 34, Issue , 2016, Pages 6-8

  Hahn, Jonas ^a   Knopf, Jasmin ^a   Maueröder, Christian ^a   Kienhöfer, Deborah ^a   Leppkes, Moritz ^a   Herrmann, Martin ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Animals (B01); Cells (A11),Immune system (A15); Immune system diseases (C20); Tissues (A10)

Indexed keywords

HISTONE H3; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; URATE;

ACUTE PANCREATITIS; ARTICLE; AUTOIMMUNE PANCREATITIS; BONE REMODELING; CHRONIC PANCREATITIS; CYTOKINE RELEASE; EXTRACELLULAR TRAP; GOUT; HUMAN; INFLAMMATION; JOINT DESTRUCTION; LEUKOCYTE ACTIVATION; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NEUTROPHILIA; NONHUMAN; PANCREAS DUCT STENOSIS; PANCREATITIS; PRIORITY JOURNAL; SYNOVITIS; ANIMAL; DISEASE MODEL; IMMUNOLOGY; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; DISEASE MODELS, ANIMAL; EXTRACELLULAR TRAPS; GOUT; HUMANS; INFLAMMATION; NEUTROPHIL ACTIVATION; NEUTROPHILS; PANCREATITIS; SIGNAL TRANSDUCTION;

EID: 84984819434     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. NATHAN C: Points of control in inflammation. Nature 2002; 420: 846-52.
2. NATHAN C: Specificity of a third kind: reactive oxygen and nitrogen intermediates in cell signaling. J Clin Invest 2003; 111: 769-78.
3. HENSON PM, JOHNSTON RB: Tissue-Injury in Inflammation-Oxidants, Proteinases, and Cationic Proteins. J Clin Invest 1987; 79: 669-74.
4. WEISS SJ: Tissue Destruction by Neutrophils. N Engl J Med 1989; 320: 365-376.
5. LETO TL, GEISZT M: Role of Nox family NADPH oxidases in host defense. Antioxid Redox Signal 2006; 8: 1549-61.
6. NORDENFELT P, TAPPER H: Phagosome dynamics during phagocytosis by neutrophils. J Leukoc Biol 2011; 90: 271-84.
7. BAZZONI F et al.: Phagocytosis of opsonized yeast induces tumor necrosis factor-alpha mRNA accumulation and protein release by human polymorphonuclear leukocytes. J Leukoc Biol 1991; 50: 223-8.
8. BAZZONI F, CASSATELLA MA, ROSSI F, CESKA M, DEWALD B, BAGGIOLINI M: Phagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide 1/interleukin 8. J Exp Med 1991; 173: 771-4.
9. BRINKMANN V, REICHARD U, GOOSMANN C et al.: Neutrophil extracellular traps kill bacteria. Science 2004; 303: 1532-5.
10. LIU X, MA B, MALIK AB et al.: Bidirectional regulation of neutrophil migration by mitogen- activated protein kinases. Nat Immunol 2012; 13: 457-64.
11. REEVES EP, LU H, JACOBS HL et al.: Killing activity of neutrophils is mediated through activation of proteases by K+ flux. Nature 2002; 416: 291-7.
12. DORING Y, SOEHNLEIN O, WEBER C: Neutrophils Cast NETs in Atherosclerosis Employing Peptidylarginine Deiminase as a Therapeutic Target. Circ Res 2014; 114: 931-4.
13. DWORSKI R, SIMON HU, HOSKINS A, YOUSEFI S: Eosinophil and neutrophil extracellular DNA traps in human allergic asthmatic airways. J Allergy Clin Immunol 2011; 127: 1260-6.
14. MARTINOD K, WAGNER DD: Thrombosis: tangled up in NETs. Blood 2014; 123: 2768-76.
15. SCHAUER C, JANKO C, MUNOZ LE et al.: Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines. Nat Med 2014; 20: 511-7.
16. RASARATNAM I, CHRISTOPHIDIS N: Gout: 'a disease of plenty'. Aust Fam Physician 1995; 24: 849-51, 855-6, 859-60.
17. HUGHES GR, BARNES CG, MASON RM: Bony ankylosis in gout. Ann Rheum Dis 1968; 27: 67-70.
18. HANZLICKOVA L, KRIZEK V: [Skin manifestations in gout]. Beitr Rheumatol 1972; 18: 54-5.
19. SCHWEYER S, HEMMERLEIN B, RADZUN HJ, FAYYAZI A: Continuous recruitment, coexpression of tumour necrosis factor-alpha and matrix metalloproteinases, and apoptosis of macrophages in gout tophi. Virchows Arch 2000; 437: 534-9.
20. YAGNIK DR, HILLYER P, MARSHALL D et al.: Noninflammatory phagocytosis of monosodium urate monohydrate crystals by mouse macrophages. Implications for the control of joint inflammation in gout. Arthritis Rheum 2000; 43: 1779-89.
21. LEE YM, FUJIKADO N, MANAKA H, YASUDA H, IWAKURA Y: IL-1 plays an important role in the bone metabolism under physiological conditions. Int Immunol 2010; 22: 805-16.
22. SRIRANGAN S, CHOY EH: The role of interleukin in the pathophysiology of rheumatoid arthritis. Ther Adv Musculoskelet Dis 2010; 2: 247-56.
23. KELKKA T, KIENHöFER D, HOFFMANN M et al.:Reactive Oxygen Species Deficiency Induces Autoimmunity with Type 1 Interferon Signature. Antioxid Redox Signal 2014; 21: 2231-45.
24. CAMPBELL AM, KASHGARIAN M, SHLOMCHIK MJ: NADPH oxidase inhibits the pathogenesis of systemic lupus erythematosus. Sci Transl Med 2012; 4: 157ra141.
25. SPANIER BW, DIJKGRAAF MG, BRUNO MJ: Epidemiology, aetiology and outcome of acute and chronic pancreatitis: An update. Best Pract Res Clin Gastroenterol 200;. 22: 45-63.
26. LANKISCH PG, APTE M, BANKS PA: Acute pancreatitis. Lancet 2015; 386: 85-96.
27. BRAGANZA JM, LEE SH, McCLOY RF, McMAHON MJ: Chronic pancreatitis. Lancet 2011; 377: 1184-97.
28. KLöPPEL G, DETLEFSEN S, CHARI ST, LONGNECKER DS, ZAMBONI G: Autoimmune pancreatitis: the clinicopathological characteristics of the subtype with granulocytic epithelial lesions. J Gastroenterol 2010; 45: 787-93.
29. LEPPKES M, MAUERöDER C, HIRTH S et al.: Externalized decondensed neutrophil chromatin occludes pancreatic ducts and drives pancreatitis. Nat Commun 2016; 7: 10973.
30. WANG Y, LI M, STADLER S et al.: Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J Cell Biol 2009; 184: 205-13.